$300 | Single User
$600 | Site License
$900 | Enterprise License

Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review
[Lowest Price Guaranteed: $300]

Published by Global Data: 08 Nov 2015 | 2461 | In Stock
Related Topics: Business , Financial , Technology

Introduction

Summary

Molecular Pharmacology Limited (Molecular Pharmacology) is a biotechnology company. The company discovers and develops analgesic and anti-inflammatory products based on the MPL-TL compound. It designs, develops and protects emerging library of oligopeptide complexes and their applications. It has entered into an US distribution and supply agreement with MPL Australia for sales, marketing and distribution rights of MPL-TL in the US. The company markets its products through pharmaceutical distributors and through collaborative dealings with companies in the US and Europe. It partners with various research companies, which include Curtin University of Technology, The Western Australian Biomedical Research Institute and Fisher Biotec. Molecular Pharmacology is headquartered in Perth, Australia.

This comprehensive SWOT profile of Molecular Pharmacology (USA) Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Molecular Pharmacology (USA) Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.

- Corporate strategy – Analyst’s summarization of the company’s business strategy.

- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.

- Company history – Progression of key events associated with the company.

- Major products and services – A list of major products, services and brands of the company.

- Key competitors – A list of key competitors to the company.

- Key employees – A list of the key executives of the company.

- Executive biographies – A brief summary of the executives’ employment history.

- Key operational heads – A list of personnel heading key departments/functions.

- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities – A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Table of Contents
for Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review

  • Table of Contents

    Section 1 - About the Company

    Molecular Pharmacology (USA) Limited - Key Information

    Molecular Pharmacology (USA) Limited - Overview

    Molecular Pharmacology (USA) Limited - Key Employees

    Molecular Pharmacology (USA) Limited - Key Employee Biographies

    Molecular Pharmacology (USA) Limited - Key Operational Heads

    Molecular Pharmacology (USA) Limited - Major Products and Services

    Molecular Pharmacology (USA) Limited - History

    Molecular Pharmacology (USA) Limited - Company Statement

    Molecular Pharmacology (USA) Limited - Locations And Subsidiaries

    Molecular Pharmacology (USA) Limited - Key Manufacturing facilities

    Head Office

    Other Locations & Subsidiaries

    Section 2 - Company Analysis

    Molecular Pharmacology (USA) Limited - Business Description

    Molecular Pharmacology (USA) Limited - Corporate Strategy

    Molecular Pharmacology (USA) Limited - SWOT Analysis

    SWOT Analysis - Overview

    Molecular Pharmacology (USA) Limited - Strengths

    Molecular Pharmacology (USA) Limited - Weaknesses

    Molecular Pharmacology (USA) Limited - Opportunities

    Molecular Pharmacology (USA) Limited - Threats

    Molecular Pharmacology (USA) Limited - Key Competitors

    Section 3 - Company Financial Performance Charts

    Molecular Pharmacology (USA) Limited - Financial Ratios

    Financial Ratios - Capital Market Ratios

    Financial Ratios - Annual Ratios

    Financial Ratios - Interim Ratios

    Financial Ratios - Ratio Charts

    Section 4 - Appendix

    Appendix

    Methodology

    Ratio Definitions

    About GlobalData

    Contact Us

    Disclaimer

    Note*: Some sections may be missing if data is unavailable for the company

List Of Tables
in Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review

List of Tables


Molecular Pharmacology (USA) Limited, Key Information

Molecular Pharmacology (USA) Limited, Key Ratios

Molecular Pharmacology (USA) Limited, Share Data

Molecular Pharmacology (USA) Limited, Major Products and Services

Molecular Pharmacology (USA) Limited, History

Molecular Pharmacology (USA) Limited, Key Employees

Molecular Pharmacology (USA) Limited, Key Employee Biographies

Molecular Pharmacology (USA) Limited, Key Operational Heads

Molecular Pharmacology (USA) Limited, Other Locations

Molecular Pharmacology (USA) Limited, Subsidiaries

Molecular Pharmacology (USA) Limited, Key Manufacturing facilities

Molecular Pharmacology (USA) Limited, Key Competitors

Molecular Pharmacology (USA) Limited, SWOT Analysis

Molecular Pharmacology (USA) Limited, Ratios based on current share price

Molecular Pharmacology (USA) Limited, Annual Ratios

Molecular Pharmacology (USA) Limited, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures, Charts and Diagrams
in Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review

List of Figures


Molecular Pharmacology (USA) Limited, Performance Chart

Molecular Pharmacology (USA) Limited, Ratio Charts

Additional Details

Publisher

Global Data

Publisher Information

Reference

2461 | GDPH222273FSA

Number of Pages

25

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Roche Molecular Systems, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryRoche Molecular Systems, Inc. (RMD), a subsidiary of F. Hoffmann-La Roche Ltd. is a biotechno...
27 Feb 2016 by Global Data USD $250 More Info
Molecular Targeting Technologies, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryMolecular Targeting Technologies Inc. (MTTI) is a biotechnology company that develops medical...
25 Feb 2016 by Global Data USD $250 More Info
HTG Molecular Diagnostics, Inc. (HTGM) - Medical Equipment - Deals and Alliances Profile
SummaryHTG Molecular Diagnostics, Inc. (HTG) is a technology company that provides molecular technol...
25 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
AlphaHelix Molecular Diagnostics AB (ALPH) - Financial and Strategic SWOT Analysis Review
SummaryAlphaHelix Molecular Diagnostics AB (AlphaHelix) is a medical device company that develops, m...
09 Jan 2016 by Global Data USD $300 More Info
AlphaHelix Molecular Diagnostics AB (ALPH) - Financial and Strategic SWOT Analysis Review
SummaryAlphaHelix Molecular Diagnostics AB (AlphaHelix) is a medical device company that develops, m...
08 Nov 2015 by Global Data USD $300 More Info
Molecular Targeting Technologies, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryMolecular Targeting Technologies Inc. (MTTI) is a biotechnology company that develops medical...
23 Oct 2015 by Global Data USD $250 More Info
Roche Molecular Systems, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryRoche Molecular Systems, Inc. (RMD) is a biotechnology company that develops, manufactures an...
23 Oct 2015 by Global Data USD $250 More Info
HTG Molecular Diagnostics, Inc. (HTGM) - Medical Equipment - Deals and Alliances Profile
SummaryHTG Molecular Diagnostics, Inc. (HTG) is a technology company that provides molecular technol...
16 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Molecular Pharmacology (USA) Limited (MLPH) - Financial and Strategic SWOT Analysis Review | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...